Scientific Presentations &
publications

 

Sort by year:
Filter
November 2024
Long-term survival of participants in a phase II randomized trial of RNS60 in amyotrophic lateral sclerosis
2024 World Stroke Congress (WSC) | October 23–26, 2024
Ghosh et al. RESCUE: A PHASE 2 TRIAL OF RNS60 SHOWS SAFETY, REDUCES INFARCT GROWTH AND DEMONSTRATES SIGNS OF EFFICACY IN SUBJECTS WITH ISCHEMIC STROKE RECEIVING MECHANICAL THROMBECTOMY
2024 European Stroke Organisation Conference (ESOC) | May 15–17, 2024
Ghosh et al. RESCUE: A PHASE 2 RANDOMIZED TRIAL SHOWS SAFETY AND EARLY SIGNS OF EFFICACY OF RNS60 AS AN ADJUNCTIVE THERAPY IN ISCHEMIC STROKE
January 2024
RNS60 shows neuroprotective effect in a mouse model of transient focal cerebral ischemia
March 2023
RNS60 induces expression of DJ-1, an important protein in Parkinson’s disease, in neuronal cells
2023 International Stroke Conference (ISC) | February 8–10, 2023
Ghosh et al. RESCUE: A RANDOMIZED, BLINDED, PLACEBO-CONTROLLED, PARALLEL GROUP DESIGN TO DETERMINE THE SAFETY OF RNS60 IN LARGE VESSEL OCCLUSION STROKE PATIENTS UNDERGOING ENDOVASCULAR THROMBECTOMY
October 2022
RNS60 Shows Protective Effects in Cardiac Ischemic Injury
September 2022
RNS60 Treatment Slows the Decline of Measures of Respiratory and Bulbar Function in a Phase 2 Trial in ALS
2022 International Stroke Conference (ISC) | February 9–11, 2022
Ghosh et al. RESCUE: A RANDOMIZED, BLINDED, PLACEBO-CONTROLLED, PARALLEL GROUP DESIGN TO DETERMINE THE SAFETY OF RNS60 IN LARGE VESSEL OCCLUSION STROKE PATIENTS UNDERGOING ENDOVASCULAR THROMBECTOMY
June 2020
RNS60 HAS THERAPEUTIC EFFECTS IN A MOUSE MODEL OF TRAUMATIC BRAIN INJURY (TBI)
March 2019
RNS60 TREATMENT WAS WELL TOLERATED IN AN OPEN LABEL CLINICAL PILOT STUDY IN ALS
June 2018
RNS60 INCREASES PRODUCTION OF NEW FUNCTIONAL MITOCHONDRIA IN NEURONAL CELLS
March 2018
RNS60 SHOWS THERAPEUTIC EFFECTS IN A MOUSE MODEL OF AMYOTROPHIC LATERAL SCLEROSIS (ALS)
February 2018
RNS60 TREATMENT UPREGULATES MYELIN GENE EXPRESSION
April 2017
RNS60 PROMOTES NEUROTRANSMISSION IN NEUROMUSCULAR JUNCTIONS
MARCH 2017
RNS60 SHOWS PROMISE AS AN INHALED THERAPY IN A MOUSE MODEL OF MULTIPLE SCLEROSIS
JULY 2016
INSIGHTS INTO THE GROWTH CHARACTERISTICS OF SURFACE MICROBUBBLES
JULY 2016
RNS60 PROTECTS MYELIN-PRODUCING CELLS IN THE BRAIN
March 2016
VISUALIZATION OF NANOBUBBLES BY CRYO-ELECTRON MICROSCOPY
January 2016
NEW TECHNIQUE TO MEASURE NANOBUBBLE LIFETIME
November 2015
MODIFIED COULTER COUNTER TECHNIQUE WITH ULTRA-HIGH RESOLUTION
August 2015
STUDY ON THE FORMATION OF SINGLE NANOBUBBLES AT PLATINUM ELECTRODES
JUNE 2015
NEW INSIGHTS INTO THE NATURE OF NANOBUBBLES
JUNE 2015
REVALESIO SCIENTISTS DEVELOP METHOD FOR SIZING OF NANOPARTICLES
January 2015
RNS60 ENHANCES MITOCHONDRIAL ATP PRODUCTION
August 2014
RNS60 HAS THERAPEUTIC EFFECTS IN AN ANIMAL MODEL OF ALZHEIMER’S DISEASE
July 2014
RNS60 TREATMENT ENHANCES NEURONAL PLASTICITY IN A MOUSE MODEL OF ALZHEIMER’S DISEASE
June 2014
REVIEW ARTICLE SUMMARIZES ADVANCES IN TECHNIQUE ANALYZING NANOPARTICLES
May 2014
NANOBUBBLES FORMING ON SURFACES EXIST IN A DYNAMIC EQUILIBRIUM
March 2014
PROMISING FINDINGS OF RNS60 IN AN ANIMAL MODEL OF PARKINSON’S DISEASE
February 2014
RNS60 ENHANCES SYNAPTIC TRANSMISSION
December 2012
NEW METHOD TO CONTROL NANOPARTICLE DYNAMICS
December 2012
RNS60 DEMONSTRATES THERAPEUTIC EFFECTS IN A MOUSE MODEL OF MULTIPLE SCLEROSIS
August 2012
RNS60 SHOWS EFFECT ON GLIAL INFLAMMATION